Skip to main content
Equibles

Soleus Capital Management, L.P.

Position in NVCR — NovoCure Ltd

CIK 1802630 GREENWICH, CT
Back to NVCR Full portfolio

Position in NVCR

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$150,188,025
+$35,820,964 QoQ
Shares Held
9,913,401
-5.5% QoQ
Ownership
8.51%
of shares outstanding
% of Portfolio
5.18%
of 13F equity value
Holder Rank
#3
of 217 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $637,521,571 across 15 Medical Devices names. NVCR ranks #2 (23.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PODD
Insulet Corp
 1,049,000 $159,710,250
2 NVCR
NovoCure Ltd
This page 		9,913,401 $150,188,025
3 INSP
Inspire Medical Systems, Inc.
 1,931,436 $86,161,359
4 BBNX
Beta Bionics, Inc.
 4,393,714 $68,849,498
5 NPCE
NeuroPace Inc
 2,911,122 $46,257,728
6 GMED
Globus Medical Inc
 468,922 $37,049,527
7 PRCT
PROCEPT BioRobotics Corp
 1,003,000 $22,647,740
8 LIVN
LivaNova PLC
 254,957 $20,965,114

All Filings in NVCR

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $150,188,025 9,913,401
2026-03-31 $114,367,061 10,492,391
2025-12-31 $110,301,498 8,530,665
2025-09-30 $124,611,746 9,644,872
2025-06-30 $122,896,575 6,904,302
2025-03-31 $98,391,597 5,521,414
2024-12-31 $81,643,179 2,739,704
2024-06-30 $1,865,457 108,900
2024-03-31 $10,874,713 695,759
2023-12-31 $4,493,930 301,000
2023-09-30 $5,557,215 344,100
2023-06-30 $10,171,650 245,100
2023-03-31 $7,818,200 130,000
2022-06-30 $922,612 13,275
2022-03-31 $1,431,233 17,275
2021-12-31 $1,672,407 22,275
2021-09-30 $3,168,536 27,275
2021-06-30 $21,954,634 98,975
2021-03-31 $3,347,458 25,325
2020-09-30 $5,830,083 52,377
2020-06-30 $3,344,342 56,397
2020-03-31 $376,901 5,597